PACB · Pacific Biosciences Of California, Inc.
Market Cap
$435.16M
Shares
310.83M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.28
Open$1.33
Day$1.28–1.34
52W close$1.11–2.67
Avg vol 30d7.3M
Short int53.4M · 17.2% float · 6.6d
Short vol47%
Last earningsAug 5, 2026
DataJan 2020–Sep 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 3, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−22%
below
Price vs 50-day avg
−9%
below
RSI (14)
46
neutral
MACD trend
Positive
52-week position
11%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−11%
trailing
6-month return
−5%
trailing
YTD return
−32%
this year
Relative strength
−18%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
-4% holders QoQ · +24 funds added
Insider flow
Distributing
Net -$30.4K over 90 days · 100% sells
Short interest
Rising
17.18% of float · ▲ +9.0% MoM · 6.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
222 holders — mid 3-yr range
Squeeze score
76
high risk · 0–100
Fundamentals
Revenue growth
+3%
Y/Y
Gross margin
49%
expanding
EPS growth
−14%
Y/Y
Free cash flow
$-113.9M
Balance sheet
$571.6M
net debt
Quant / Vol
risk profile
Volatility
89%
annualized · 1-yr
Max drawdown
−58%
past year
ATR
8.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−22%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
46
Neutral
MACD trend
Positive
Bullish
52-week position
11%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
-4% holders QoQ · +24 funds added
Insider flow
Distributing
Net -$30.4K over 90 days · 100% sells
Short interest
Rising
17.18% of float · ▲ +9.0% MoM · 6.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
222 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 11%
Range high $3
vs 200-day avg -22%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PACB
this stock
Pacific Biosciences Of California, Inc.
|
$435.16M | -31.6% | +3.0% | — | 17.2% |
|
ABT
Abbott Laboratories
|
$191.81B | -13.1% | +5.7% | 30.9 | 1.2% |
|
SYK
Stryker Corp
|
$126.84B | -9.7% | +11.2% | 34.3 | 1.8% |
|
MDT
Medtronic plc
|
$117.82B | -4.2% | +8.4% | 24.7 | 1.1% |
|
BSX
Boston Scientific Corp
|
$70.00B | -49.6% | +12.5% | 19.6 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PACB | -15.8% | -11.1% | -5.2% | -5.5% | -31.6% |
| SPY | -0.5% | -1.2% | +12.6% | -0.7% | +11.7% |
| vs SPY | -15.3% | -9.9% | -17.8% | -4.9% | -43.3% |